A detailed history of Sarissa Consulting LLC transactions in Meridian Bioscience Inc stock. As of the latest transaction made, Sarissa Consulting LLC holds 18,267 shares of VIVO stock, worth $0. This represents 0.59% of its overall portfolio holdings.

Number of Shares
18,267
Holding current value
$0
% of portfolio
0.59%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

BUY
$30.9 - $33.55 $564,450 - $612,857
18,267 New
18,267 $576,000

Others Institutions Holding VIVO

About MERIDIAN BIOSCIENCE INC


  • Ticker VIVO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 43,748,000
  • Description
  • Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, ...
More about VIVO
Track This Portfolio

Track Sarissa Consulting LLC Portfolio

Follow Sarissa Consulting LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sarissa Consulting LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sarissa Consulting LLC with notifications on news.